Alaunos Therapeutics, Inc. /
Velaris Therapeutics, Inc.
Alaunos Therapeutics, Inc. completed its deal for Velaris Therapeutics, Inc.
Source for the buyer and target: Alaunos Therapeutics, Inc.
For the buyer and target.
“On October 13, 2026, Alaunos Therapeutics, Inc., a Delaware corporation (the “Company” or “Alaunos”), acquired Velaris Therapeutics, Inc., a Delaware corporation (“Velaris”), in accordance with the terms of the Agreement and Plan of Merger, dated October 13, 2026 (the “Merger Agreement”), by and among the Company, Valkyrie Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“First Merger Sub”), Valkyrie Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Second Merger Sub”), and Velaris.”
Published 13 Oct 2026
Open the sourceWhat happened
The deal for Velaris Therapeutics, Inc. has closed, with Alaunos Therapeutics, Inc. as the buyer. [01]
The filing from Alaunos Therapeutics, Inc. is dated Oct. 13, 2026. [01]
Who is involved, and the source
Everything on this page comes from the source below, quoted word for word.
Advisers
Buy side
- Financial adviser to the buyerCantorSource: SEC filing, as of 13 Oct 2026
- Legal adviser to the buyerSichenzia Ross Ference Carmel LLPSource: SEC filing, as of 13 Oct 2026
Target
- Financial adviser to the targetWedbush Securities Inc.Source: SEC filing, as of 13 Oct 2026
- Legal adviser to the targetGibson, Dunn & Crutcher LLPSource: SEC filing, as of 13 Oct 2026
Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.
Alaunos Therapeutics, Inc. completed its deal for Velaris Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly